Member Info for Mikethebat

I bought in very early, because I thought they have good products just waiting for certification and they have good boffins who know whats needed in the bio med world. With an equity company backing and putting a worldwide selling/marketing platform in place, and once the FDA gives it the seal of approval, thats take off Im buying more

This company definitly needs a Marketing Director to pull all companies together and then you would see great results, They are good Bio Medic engineers/R & D etc but someone to get out there and sell would be a positive move. They have the hook as we say in the marketing business

Should Alan John Audrey still be listed on the Director buys (above) when in fact the shares were bought then sold the vsame day as he passed away on or about that date. Just interested

Positive me yes, a British company with good products in their early stages and with the Midas product they have a winner which will sell well in the States. I own horses and Midas will save a lot of time when it comes to diagnosing complaints and save the owner money and that goes for all animals. Then comes the prompt human diagnosis. I am a definite buy for more

There just might be a tieup with UCB Pharma!!

MIDAS is the Company's rapid immunodiagnostic device prototype aimed at detecting disease markers in biological fluids such as blood and urine. MIDAS will be focused initially on the veterinary diagnostics market and is the natural application of Avacta's core analysis technologies and commercialisation skills in the diagnostics sector. As the route to market is easier for veterinary products, this will allow the Company to generate revenues more quickly, while continuing to develop and adapt the tests for human diagnostics use. As announced post period end, Avacta acquired YorkTest Veterinary Services Limited with a view to developing MIDAS and launching the product later in the year and has secured an extensive network of potential clients throughout the EU and the UK with the acquisition. Avacta has delivered two gas detection prototypes based on the infra-red absorption technology acquired with Oxford Medical Diagnostics in 2008 to its commercial partners. Both prototype devices, one to quantify moisture content in complex gas mixtures and the other to detect the presence of a toxic gas, have outperformed the technical specifications set by the commercial partners and the directors anticipate that product engineering will proceed with these partners during the rest of 2009 leading to product launches in 2010. Clinical gas analysis collaboration : Currently clinical headspace gas analysis to detect bacterial infections requires large and very expensive centralised equip

Alastair Smith, Chief Executive Officer, commented: "Avacta is in the transition period from a research and development phase toward being a revenue generating, high value products and services company. In almost all regards it has met our ambitious expectations within the short period since our formation and we believe that in our field, our expertise is world leading. We look forward to the remainder of the year with eagerness and to updating you as we progress

MBH

Thanks for the info, I am in this one long term, and this guy knows his stuff and has been there before, great, good management is Buffetts keyword, Like I posted on Michaelmersh, if you like something simple(no hi tech) again like Buffett in his book, then Im in Cheers

Rock Island Capital was the website I found and wondered whether it was the same. I delt with many Venture Capital companies Stateside in the Aerospace when I was with Hawker, BTR etc and they were always itching to get into British Companies I like this company and I am sure the directors will deal a goog hand to the shareholders but we want to hear reassuring noises

They could fit easily into their portfolio of companies, check out their web site

Pressed wrong button. I agree with you moneybagz about Mano, I have been in for a year now and they were always a strong buy with HSBC taking a wedge some time ago

Michelmersh Brick Holdings (LSE: MBH.L - news) , whose bricks were used to build London's new St. Pancras rail station, is to launch a terracotta production business.

Spitfire produces oil from low-grade coal; shares surge Jan 12 (Reuters) - Fuel-oil producer Spitfire Oil Ltd (LSE: SRO.L - news) said on Monday it produced the first oil from low-grade coal at its new test reactor in Western Australia, sending its shares up as much as 169 percent. 'This result brings one step closer the possibility of converting Spitfire's current resource of 500 million tonnes of lignite at Salmon Gums into at least 200 million barrels of oil,' the company said. Spitfire expects to produce up to 20,000 barrels of oil per day from Western Australia's first low-carbon footprint coal-to-liquids business, once the process technology is scaled to commercial levels. Spitfire has already invested about A$10 million ($6.93 million) in Western Australia through its technology development and drilling programs. Spitfire estimates a total capital expenditure of about $1.3 billion (in 2008 dollar value). Its projected operational cost is $18 per barrel of oil produced, with a breakeven price (generating a 9 percent return on capital) of $40 per barrel. The company has tied up with Curtin University of Technology in Western Australia to develop a pyrolysis process that operates at lower temperatures, resulting in much lower greenhouse gas emissions. The new technology would cost A$4.1 per barrel of produced oil while the more conventional process would cost more than A$16.6 per barrel, it said.

Raymarine has been looking for a partner to rescue the business as it battles falling profits and mounting debts. A deal with Garmim would dominate different parts of the navigation-systems markets but are vastly different in size. Portsmouth-based Raymarine is one of the world’s largest marine electronics firms, supplying autopilot, GPS and fish-finding systems for leisure boats. The company’s products have been used by Ellen MacArthur during her round-the-world voyages. Garmin, based in the Cayman Islands, is a leading manufacturer of global navigation devices and is valued at nearly $6 billion (£3.6 billion) on the Nasdaq stock exchange. As well as the marine industry, its products are used in mobile phones, aviation and outdoor pursuits. The business has made billionaires of its founders Gary Burrell and Min Kao. Both companies face challenges. Raymarine’s profits fell last year by more than 50% to just under £11m. This pushed the company to the limit of its banking facilities, Garmin also lost ground to compeitors. Garmin a Cayman Company Ahhh could be the one

Is a Private Equity company sniffing, could be Rock Island Capital, plenty of money if its this company, US based

Mike the Bat Blurb

Rumour of the day Industry chatter has it that China Minmetals, the state-owned miner that bought Oz Minerals’ Australian mines for $1.3 billion (£802 million) last month, is eyeing a bid for Griffin Mining, steady at 33¼p, which, aside from a Chinese zinc mine, has a 39 per cent holding in Spitfire Oil, up 3p to 19p. Spitfire owns technology that can convert coal deposits to oil.

This share has to go north soon, the housing market has not bit the bullet yet, but plenty of growth now they seem to have put their house in order

Small is beautiful, my gut feeling is certainly for the longer term